Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,793,431 papers from all fields of science
Search
Sign In
Create Free Account
Recombinant RANTES
Known as:
Regulated on Activation, Normal T Expressed and Secreted
, T-Cell RANTES Protein
, CCL5
Expand
A member of the IL-8 superfamily of cytokines and released from platelets and activated T-cells, RANTES is a selective chemoattractant for…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
CCL5 gene
CCL5 protein, human
CCL5 wt Allele
RANTES
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Effect of CCL5 on dimethylarginine dimethylaminohydrolase-1 production in vascular smooth muscle cells from spontaneously hypertensive rats.
Hye Young Kim
,
J. Kim
,
H. Kim
Cytokine
2013
Corpus ID: 21496724
Highly Cited
2008
Highly Cited
2008
Intrasplenic trafficking of natural killer cells is redirected by chemokines upon inflammation
C. Grégoire
,
C. Cognet
,
+7 authors
T. Walzer
European Journal of Immunology
2008
Corpus ID: 21875797
The spleen is a major homing site for NK cells. How they traffic to and within this site in homeostatic or inflammatory…
Expand
2008
2008
Leukotriene B4 is essential for selective eosinophil recruitment following allergen challenge of CD4+ cells in a model of chronic eosinophilic inflammation.
Alessandra B Cheraim
,
P. Xavier-Elsas
,
+4 authors
F. Cunha
Life Science
2008
Corpus ID: 2551465
2007
2007
Allosteric effects of antagonists on signalling by the chemokine receptor CCR5.
B. Haworth
,
Hong Lin
,
M. Fidock
,
P. Dorr
,
P. Strange
Biochemical Pharmacology
2007
Corpus ID: 28809476
2006
2006
Dynamic T‐lymphocyte Chemokine Receptor Expression Induced by Interferon‐beta Therapy in Multiple Sclerosis
M. Krakauer
,
P. S. Sørensen
,
M. Khademi
,
T. Olsson
,
F. Sellebjerg
Scandinavian Journal of Immunology
2006
Corpus ID: 36352629
Treatment with interferon (IFN)‐β reduces clinical disease activity in multiple sclerosis (MS). Using flow cytometry, an enzyme…
Expand
2006
2006
Generation of GPI-linked CCL5 based chemokine receptor antagonists for the suppression of acute vascular damage during allograft transplantation.
M. Notohamiprodjo
,
Roghieh Djafarzadeh
,
Anke Mojaat
,
I. von Lüttichau
,
H. Gröne
,
P. Nelson
Protein engineering, design & selection : PEDS
2006
Corpus ID: 37930108
Limiting the acute vascular damage associated with leukocyte infiltration is a central issue in solid organ transplantation. The…
Expand
2005
2005
Chemokines in onchocerciasis patients after a single dose of ivermectin
J. Fendt
,
David Michael Hamm
,
+5 authors
P. Soboslay
Clinical and Experimental Immunology
2005
Corpus ID: 25310683
Ivermectin treatment will effectively diminish microfilariae (Mf) of Onchocerca volvulus in the skin of patients, but therapy is…
Expand
2003
2003
The Effect of Nasal Polyp Epithelial Cells on Eosinophil Activation
Seung-Heon Shin
,
Sang‐Heon Lee
,
H. Jeong
,
H. Kita
The Laryngoscope
2003
Corpus ID: 22374429
Objectives/Hypothesis Eosinophil infiltration into an inflammatory site is a characteristic histological finding in patients with…
Expand
2000
2000
Limited expression of R5-tropic HIV-1 in CCR5-positive type 1-polarized T cells explained by their ability to produce RANTES, MIP-1alpha, and MIP-1beta.
F. Annunziato
,
G. Galli
,
+5 authors
S. Romagnani
Blood
2000
Corpus ID: 22135517
Human T helper (Th) cells (Th1- or Th2-oriented memory T cells as well as Th1- or Th2-polarized naive T cells) were infected in…
Expand
1996
1996
Differential regulation of (31 and 082 integrin avidity by chemoattractants in eosinophils
C. Weber
,
J. Kitayama
,
T. Springer
1996
Corpus ID: 44218423
The CC chemokines regulated on activation normal T expressed and secreted (RANTES) and monocyte chemotactic protein 3 (MCP-3…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE